Off-label and unlicensed drug use in neonatal intensive care units in Turkey: the old-inn study

S Suna Oguz1, H Gozde Kanmaz, Ugur Dilmen

  • 1Neonatal Intensive Care Unit, Zekai Tahir Burak Maternity Teaching Hospital, 06230, Cebeci, Ankara, Turkey.

Insights

Unlicensed and off-label drug use is common in Turkish neonatal intensive care units (NICUs), affecting over 60% of prescriptions for infants. This highlights an urgent need for safer medication practices for neonates.

Area of Science:

  • Neonatal pharmacology
  • Pediatric drug safety
  • Clinical pharmacy

Background:

  • Developed countries have improved drug safety for infants and pediatric patients.
  • Many drugs used in children are unlicensed or prescribed off-label.
  • Licensed drug approvals for adults specify indications, doses, and administration routes.

Purpose of the Study:

  • To assess the extent and nature of unregistered and off-label drug use in Turkish neonatal intensive care units (NICUs).
  • To explore public awareness and views on unlicensed medicine use in preterm and term infants in developing countries.

Main Methods:

  • Prospective observational study of 464 neonates across 17 NICUs in Turkey.
  • Recording all medications administered to neonates over a 24-hour period.
  • Analyzing prescriptions for licensed versus unlicensed or off-label use.

Main Results:

  • A total of 1,315 prescriptions for 93 different medicines were analyzed.
  • 62.3% of all prescribed drugs were used in an unlicensed or off-label manner.
  • High prevalence of off-label and unlicensed medication use in neonates.

Conclusions:

  • Unlicensed and off-label medicines are frequently administered to preterm and term infants in Turkish NICUs.
  • This finding is consistent with reports from other countries.
  • Urgent attention is required to prioritize the needs of the neonatal population and ensure access to safe, appropriate medicines.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...